The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 08, 2017

Filed:

Jun. 20, 2014
Applicant:

Lupin Limited, Mumbai, Maharashtra, IN;

Inventors:

Nageswara Rao Irlapati, Maharashtra, IN;

Nilesh Raghunath Khedkar, Maharashtra, IN;

Ravindra Babanrao Jape, Maharashtra, IN;

Rahul Shripad Nandurdikar, Maharashtra, IN;

Zubair Abdul Wajid Shaikh, Maharashtra, IN;

Neelima Sinha, Maharashtra, IN;

Venkata P. Palle, Maharashtra, IN;

Rajender Kumar Kamboj, Maharashtra, IN;

Assignee:

LUPIN LIMITED, Mumbai, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/04 (2006.01); C07D 263/58 (2006.01); C07D 265/36 (2006.01); C07D 413/04 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 417/04 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
C07D 498/04 (2013.01); A61K 31/5377 (2013.01); C07D 263/58 (2013.01); C07D 265/36 (2013.01); C07D 413/04 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01);
Abstract

The invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine for the treatment of diseases, disorders associated with the modulation of calcium release-activated calcium (CRAC) channel. The invention also relates to pharmaceutical compositions containing such compounds in treating diseases disorders associated with calcium release-activated calcium (CRAC) channel modulators. wherein, ring D is Formula (a) or Formula (b): A and B, which may be same or different, are independently CRor N; Y is CRor N; L is selected from —NRC(O)—, —C(O)NR— and —NRCRR—; Rand Rare independently hydrogen, halogen or substituted or unsubstituted alkyl; ring E is selected from the Formula (i) to (vii).


Find Patent Forward Citations

Loading…